CollPlant (CLGN) news
Recent news
L&T to report Q2 results on Oct. 27
AInvest Wire · 1d agoCollplant Biotechnologies - To use proceeds to accelerate Lightsolver R&D programs
CollPlant Biotechnologies (NASDAQ: CLGN) has announced plans to allocate a portion of its recent capital proceeds to accelerate the research and development (R&D) programs of its newly acquired subsidiary, LightSolver. This strategic move aims to enhance CollPlant’s capabilities in photonic…
AInvest Wire · 5d agoCollplant reports a $3.7M placement
AInvest Wire · 5d agoCollplant Biotechnologies - Unit files U.S. provisional patent application expanding photonic computing platform
CollPlant Biotechnologies, a regenerative and aesthetic medicine company, has filed a U.S. provisional patent application that expands its photonic computing platform, signaling continued innovation in its 3D bioprinting and tissue engineering technologies. The filing is part of the company’s…
AInvest Wire · Oct 6, 2026Collplant regains compliance with Nasdaq minimum bid price requirement
AInvest Wire · Sep 22, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.